BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

SSI INVESTMENT MANAGEMENT LLC's Holding History (CIK: 0000938487)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,500,000 Value ($000) $6,174 Avg Close — Range —
Q3 2025
Shares 5,500,000 Value ($000) $5,415 Avg Close — Range —
Q2 2025
Shares 5,500,000 Value ($000) $5,121 Avg Close — Range —
Q1 2025
Shares 3,750,000 Value ($000) $3,362 Avg Close — Range —
Q4 2024
Shares 4,500,000 Value ($000) $3,839 Avg Close — Range —
Q3 2024
Shares 4,500,000 Value ($000) $3,758 Avg Close — Range —
Q2 2024
Shares 4,500,000 Value ($000) $3,607 Avg Close — Range —
Q1 2024
Shares 3,000,000 Value ($000) $2,443 Avg Close — Range —
Q4 2023
Shares 2,125,000 Value ($000) $1,800 Avg Close — Range —
Q3 2023
Shares 8,217,000 Value ($000) $6,122 Avg Close — Range —